please click on the headlines below to read the complete article
Lenalidomide (Revlimid®) has been added to the Newfoundland and Labrador Prescription Drug Program (NLPDP) Benefit List for newly diagnosed multiple myeloma patients, following autologous stem-cell transplantation (ASCT) (for maintenance treatment) - Effective December 1, 2014.
Lenalidomide (Revlimid®) has been added to the New Brunswick Drug Plans Formulary when used as maintenance treatment of patients with newly diagnosed multiple myeloma, following autologous stem-cell transplantation (ASCT), who have stable disease or better, with no evidence of disease progression. - Effective December 12, 2014.
ASH 2014: The Latest on Blood Cancers – From Advances to Patient Advantages - On Sunday, December 7, 2014, at 8 p.m., live from San Francisco, where the 56th American Society of Hematology (ASH) Annual Meeting is taking place, leading blood cancer experts, advocacy organizations and patients will put data into perspective, showcasing how scientific advances help patients. A recording of the webcast will be available on December 8th. We will share a link to the webcast shortly.
The news briefing is being hosted by Myeloma Canada, the International Myeloma Foundation, the Lymphoma Research Foundation, the MDS Foundation on behalf of the MDS Alliance and the National Patient Advocate Foundation. Join the conversation around the briefing using the hashtag#BCBrief14
Government adds 10 medications to Provincial Pharmacare in Prince Edward Island -
Effective November 18, 2014 - Government is enhancing drug programs by adding 10 new drugs - or new indications for existing drugs - to help Islanders battle disease, says Health and Wellness Minister Doug Currie. Find more information on the Catastrophic Drug Program here.
For those of you who wish to follow the discussion, we will be live tweeting about the Summit and the Awareness Day (@MyelomaCanada). You can also follow the hashtag #makemyelomamatter. Be part of the conversation.
Click here to access the Advocacy Summit Toolkit.
Myeloma Canada is affiliated with the International Myeloma Foundation, the world's oldest and largest myeloma organization
Myeloma Canada gratefully acknowledges the generous unrestricted educational grants from our website sponsors: